📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Predicting Drug-Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling. (2019)

First Author: Rajoli RKR

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/infdis/jiy726

PubMed Identifier: 30566691

Publication URI: http://europepmc.org/abstract/MED/30566691

Type: Journal Article/Review

Volume: 219

Parent Publication: The Journal of infectious diseases

Issue: 11

ISSN: 0022-1899